(PharmaNewsWire.Com, June 14, 2017 ) The Europe market for anticoccidial drugs is estimated to grow from $699million in 2015 to $830 Million by 2020 at a CAGR of 3.5%. Coccidiosis, a parasitic infection of the intestinal tract of animals is caused by coccidian protozoa. The disease feasts from one animal to another by any contact with infected faeces or consumption of infected tissue. It infects a wide variety of animals, such as cattle, poultry, pigs and sheep which is effecting the volumes of meat production. To overcome this problem, anticoccidial drugs play an important role in the prevention and treatment of coccidiosis.
The ban on consumption of antibiotics as a source of animal feed and the upsurge in incidences of antibiotic microbes has seen a reduced growth in the antibiotic market, nevertheless the rising incidence of coccidiosis over the preceding 50 years and its control on the overall cost to benefit ratio for the meat industry has improved the anticoccidials drug market. In addition, the growing consumer preferences for healthy diet is increasing the demand for meat proteins. This is further leading to the rise in usage of anticoccidial drugs by farmers, driving the European anticoccidial drugs market. The trend of owning companion animals is a causative to the mounting demand for anticoccidials in developed regions.
The Europe anticoccidial drugs market is classified based on various types of animals and by type of drugs. The animal segment is sub-categorised into swine, fish, poultry, cattle and companion animals. The companion animals segment is further analysed under dogs and cats. The livestock industry is currently enjoying the high growth rate owing to the increasing demand for meat in the European countries. And on the basis of drug type the market is segmented into antibiotic anticoccidials, Ionophore anticoccidials and chemical derivative anticoccidials. Furthermore, on the basis of geography, the European Market is analysed under various regions namely, UK, Spain, Italy, Germany and France.
The major players in the industry are facing various challenges related to microbial resistance build-up to therapeutics and government regulations in European Union. For this reason, many companies prefer to operate in less regulated markets. Some of the key players operating in the market are Bayer Health care, Boehringer Ingelheim Animal Health, Elanco, Merial, Merck Animal Healthcare, Virbac, Zoetis, Ceva Santé Animale, Novartis Animal Healthcare and Smartvet Inc.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
